Back to search
FDAFDA · Food and drugs·Recall number D-0491-2019

Diltiazem HCl CD capsules, 360 mg, 90-count bottles, Rx Only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7 Canada; NDC 68682-521-01.

Published February 20, 2019 · Recall initiated: January 30, 2019

Summary

FDA records drug Class III recall D-0491-2019, published February 20, 2019 and initiated January 30, 2019. Recalling firm: Valeant Pharmaceuticals North America LLC; Status: Terminated; Reported quantity: 23,884 bottles; Lot: Lots: 18J035P, 18K094P, 18K093P, Exp 09/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Valeant Pharmaceuticals North America LLC
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lots: 18J035P, 18K094P, 18K093P, Exp 09/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diltiazem HCl CD capsules, 360 mg, 90-count bottles, Rx Only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7 Canada; NDC 68682-521-01. recalled?

Yes. FDA published recall D-0491-2019 on February 20, 2019. Reported hazard: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

What should I do if I have this product?

Voluntary: Firm initiated · Letter